|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.8 JOD | +1.45% |
|
-.--% | -.--% |
Beit Jala Pharmaceutical Company reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was JOD 7.22 million compared to JOD 7.63 million a year ago. Net income was JOD 1.62 million compared to JOD 1.6 million a year ago.
Basic earnings per share from continuing operations was JOD 0.231 compared to JOD 0.229 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 27.65M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| +9.78% | 210B | |
| -5.52% | 206B | |
| +6.17% | 164B |
BEIT JALA PHARMACEUTICAL COMPANY 
